Literature DB >> 2225488

Factors influencing urinary 6-sulphatoxymelatonin, a major melatonin metabolite, in normal human subjects.

C J Bojkowski1, J Arendt.   

Abstract

6-Sulphatoxymelatonin (aMT6s) has been measured, by a direct radioimmunoassay, in urine from 130 normal volunteers aged 2-80 years. Its relationship to a number of physiological parameters has been assessed. Total urinary excretion of aMT6s did not vary in a group of 40 children aged 2-20 years (24 boys and 16 girls) except when expressed as a function of body weight. In this case, total aMT6s excretion over 24 h decreased as a function of age. In 90 adult volunteers (44 men and 46 women) aged 20-80 years, there was an age-related decline in total 24 h aMT6s excretion with significantly lower values in elderly subjects. In this same adult group no relationships were found between total aMT6s excretion and body weight or height. No sex differences were found either in the 2-20 years or the 20-80 years groups. Pineal calcification was assessed by lateral skull X-ray in 26 adult volunteers (17 men and 9 women) aged 20-50 years. No significant differences in aMT6s excretion were found as a function of pineal calcification. In 16 of these subjects plasma melatonin and aMT6s also showed no relationship to pineal calcification. These studies confirm the usefulness of aMT6s as an index of melatonin secretion in normal volunteers.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2225488     DOI: 10.1111/j.1365-2265.1990.tb03882.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  18 in total

1.  The delayed sleep phase syndrome: clinical and investigative findings in 14 subjects.

Authors:  B Alvarez; M J Dahlitz; J Vignau; J D Parkes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-08       Impact factor: 10.154

2.  Circadian rhythm disruption in severe sepsis: the effect of ambient light on urinary 6-sulfatoxymelatonin secretion.

Authors:  Avelino C Verceles; Leann Silhan; Michael Terrin; Giora Netzer; Carl Shanholtz; Steven M Scharf
Journal:  Intensive Care Med       Date:  2012-05       Impact factor: 17.440

3.  Pharmacokinetics of melatonin in preterm infants.

Authors:  Nazakat M Merchant; Denis V Azzopardi; Ahmed F Hawwa; James C McElnay; Benita Middleton; J Arendt; Tomoki Arichi; Pierre Gressens; A David Edwards
Journal:  Br J Clin Pharmacol       Date:  2013-11       Impact factor: 4.335

4.  Shift Work, Chronotype, and Melatonin Rhythm in Nurses.

Authors:  Pedram Razavi; Elizabeth E Devore; Archna Bajaj; Steven W Lockley; Mariana G Figueiro; Vincent Ricchiuti; W James Gauderman; Susan E Hankinson; Walter C Willett; Eva S Schernhammer
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-05-29       Impact factor: 4.254

Review 5.  The contribution of extrapineal sites of melatonin synthesis to circulating melatonin levels in higher vertebrates.

Authors:  G Huether
Journal:  Experientia       Date:  1993-08-15

6.  Estimation of time of death by quantification of melatonin in corpses.

Authors:  H Mikami; K Terazawa; T Takatori; S Tokudome; T Tsukamoto; K Haga
Journal:  Int J Legal Med       Date:  1994       Impact factor: 2.686

7.  Does bright light suppress nocturnal melatonin secretion more in women than men?

Authors:  P Monteleone; G Esposito; A La Rocca; M Maj
Journal:  J Neural Transm Gen Sect       Date:  1995

Review 8.  Light, melatonin and the sleep-wake cycle.

Authors:  G M Brown
Journal:  J Psychiatry Neurosci       Date:  1994-11       Impact factor: 6.186

Review 9.  Clinical aspects of the melatonin action: impact of development, aging, and puberty, involvement of melatonin in psychiatric disease and importance of neuroimmunoendocrine interactions.

Authors:  F Waldhauser; B Ehrhart; E Förster
Journal:  Experientia       Date:  1993-08-15

10.  Sleep duration, melatonin and breast cancer among Chinese women in Singapore.

Authors:  Anna H Wu; Renwei Wang; Woon-Puay Koh; Frank Z Stanczyk; Hin-Peng Lee; Mimi C Yu
Journal:  Carcinogenesis       Date:  2008-04-30       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.